Dr. Carl C. Askren, MD

Dr. Askren practices at Renaissance Surgery Center - Fresno in Fresno, California.

Dr. Askren's NPI, 1134188097, was assigned on March 20, 2006. Dr. Askren graduated from Emory School of Medicine in 1984. Dr. Askren holds California license G60139.

Dr. Askren's primary practice is Renaissance Surgery Center - Fresno, at 2365 E Fir Ave, Fresno, CA 93720. The practice phone is (559) 974-0885.

Dr. Askren's primary practice is Renaissance Surgery Center - Fresno in Fresno, California. Dr. Askren is also affiliated with Saint Agnes Medical Center. The medical group on file is Central California ENT Medical Group. Dmand AI also links Dr. Askren to 1 more hospital, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Askren practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Askren's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Askren is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Askren's licenses on file in 3 states: California, Alabama and Georgia.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Askren treats.

CMS data shows 79 Medicare services from Dr. Askren across 1 procedure code in 2024, all of them office visits, for 93 Medicare patients. Medicare paid $3,341 for them. Every service was in an office.

CMS counts 93 Medicare patients who saw Dr. Askren in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Askren's median patient age at 65, with 85% women.

In 2024, Dr. Askren wrote 126 Medicare Part D claims for 31 patients. 100% of them were for generic drugs. CMS names the drug for 101 of them, across 4 drugs with 11 or more claims each, at $1,089 in total drug cost. In 2023, CMS named 138 claims across 5 drugs.

Dr. Askren accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Askren. The most frequent topics are Lens, Crystalline, Spectrum Analysis, Raman and Aging. Dr. Askren has published most often in Exp Eye Res. Dr. Askren's most frequent co-author is Grady Bruce Core, MD.

Dmand AI links Dr. Askren to 1 clinical trial. Open Payments lists research payments to Dr. Askren that name 1 trial.

CMS Open Payments shows 392 general payments to Dr. Askren from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. TELA Bio, Inc. paid the most, $6,821. It also lists 1 research payment totaling $250 in 2020, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Askren.

Dr. Askren graduated from Emory School of Medicine in 1984. Dr. Askren is a member of ACS and ASPS.

Dr. Askren is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.